Patrick Geraghty, MD
Vascular Surgery · Saint Louis, MONPI 1376560821
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Bard Peripheral Vascular, Inc. accounts for 64.7% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2021 at $36,227 and has fallen 92.8% since, to $2,624 in 2025. Among vascular surgery clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 219 payments — averaging $298.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$42K
- Boston Scientific$7K
- Medtronic$3K
- W. L. Gore & Associates, Inc.$2K
- Limflow Inc.$2K
- Elite Orthopedics, LLC$1K
- plus $8K from 26 others
Across 49 payments — averaging $2726.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inspiremd Ltd$52K
- Boston Scientific$35K
- W. L. Gore & Associates, Inc.$16K
- Inari Medical, Inc.$12K
- Bard Peripheral Vascular, Inc.$8K
- Cook Research Incorporated$6K
- plus $4K from 1 others
What the payments were for
- Consulting fees$38,34459%
- Travel & lodging$10,87617%
- Food & beverage$14,95523%
- Education$1,2002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 34 | $42,301 |
| Boston Scientific | 18 | $6,858 |
| Medtronic(2 entities) | 32 | $3,443 |
| W. L. Gore & Associates, Inc. | 35 | $2,272 |
| Limflow Inc. | 8 | $1,610 |
| Elite Orthopedics, LLC | 1 | $1,200 |
| Inspiremd Ltd | 10 | $1,073 |
| Penumbra, Inc. | 7 | $969 |
| Surmodics, Inc. | 14 | $917 |
| Philips North America LLC | 11 | $857 |
| Intact Vascular, Inc. | 2 | $770 |
| Inari Medical, Inc. | 6 | $567 |
| Cook Medical LLC | 8 | $456 |
| Silk Road Medical, Inc. | 4 | $433 |
| Veryan Medical Incorporated | 3 | $392 |
| Shockwave Medical, Inc | 6 | $378 |
| Abbott | 1 | $163 |
| Avantec Vascular Corporation | 1 | $122 |
| Bolton Medical Inc | 3 | $89 |
| Stryker | 1 | $79 |
| Endologix LLC | 1 | $69 |
| Asahi Intecc USA, Inc. | 1 | $51 |
| Cardiovascular Systems Inc. | 2 | $51 |
| Neuros Medical, Inc. | 1 | $49 |
| Centerline Biomedical Inc. | 2 | $48 |
| Cordis US CORP. | 1 | $36 |
| Shape Memory Medical Inc. | 1 | $30 |
| Terumo Medical Corporation | 1 | $28 |
| Biotronik Inc. | 1 | $19 |
| Medical Device Business Services, Inc. | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $13 |
| Davol Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LUTONIX$15,072
- LIFESTREAM$5,495
- GENERAL VASCULAR INTERVENTION$5,291
- TurboHawk$1,593
- LIMFLOW SYSTEM$1,509
- Tack Endovascular System$770
- ENROUTE Transcarotid Neuroprotection System$746
- FLOWTRIEVER CATHETER, S$695
- GORE VIABAHN VBX Balloon Expandable Endo$675
- CLINICAL TRIAL PRODUCT$656
- Pounce Thrombectomy System$558
- GENERAL - THERAPIES$483
- Pounce Venous Thrombectomy System$452
- Abre$449
- Indigo System$443
- GORE VIABAHN Endoprosthesis$415
- CGuard$413
- ENROUTE Transcarotid Stent$373
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$373
- CGuard Prime Carotid Stent System$367
How this compares
$65,375 in reported general payments places this provider in the 90th percentile of 92 vascular surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 38 | $29,469 |
| ClopidogrelClopidogrel Bisulfate | 122 | $970 |
| Prednisone | 19 | $26 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Saint Louis
- Jeffrey JimSaint Louis$1.2M
- Brian PetersonSaint Louis$216K
- Luis SanchezSaint Louis$178K
- Catherine WittgenSaint Louis$139K
- John OhmanSaint Louis$113K
- Nathan DrozSaint Louis$38K
- Mohamed ZayedSaint Louis$30K
- Vipul KhetarpaulSaint Louis$23K
- Zachary WankenSaint Louis$18K
- Matthew SmedsSaint Louis$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.